Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
|
October 24, 2020
Reduction of cardiac dose using respiratory-gated MR-linac plans for gastro-esophageal junction cancer
Sangjune Laurence Lee, Peter Mahler, Stephanie Olson, et al.
Frontiers in Oncology
|
September 14, 2016
Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials
Harvey C Quon, Hima Bindu Musunuru, Patrick Cheung, et al.
Brachytherapy
|
November 26, 2015
Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcome
Ee Siang Choong, Peter Bownes, Hima Bindu Musunuru, et al.
The Journal of Urology
|
August 30, 2016
Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience
Hima Bindu Musunuru, Toshihiro Yamamoto, Laurence Klotz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 4, 2014
A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boost
Joelle Helou, Gerard Morton, Liying Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 3, 2018
Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life
Hima Bindu Musunuru, Laura D'Alimonte, Melanie Davidson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 29, 2018
Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials
Yasir Alayed, Patrick Cheung, Geordi Pang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2021
Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy Boost
Hima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 5, 2021
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of life
Hima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2016
Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate Cancer
Hima Bindu Musunuru, Melanie Davidson, Patrick Cheung, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
|
October 24, 2020
Reduction of cardiac dose using respiratory-gated MR-linac plans for gastro-esophageal junction cancer
Sangjune Laurence Lee, Peter Mahler, Stephanie Olson, et al.
Frontiers in Oncology
|
September 14, 2016
Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials
Harvey C Quon, Hima Bindu Musunuru, Patrick Cheung, et al.
Brachytherapy
|
November 26, 2015
Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcome
Ee Siang Choong, Peter Bownes, Hima Bindu Musunuru, et al.
The Journal of Urology
|
August 30, 2016
Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience
Hima Bindu Musunuru, Toshihiro Yamamoto, Laurence Klotz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 4, 2014
A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boost
Joelle Helou, Gerard Morton, Liying Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 3, 2018
Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life
Hima Bindu Musunuru, Laura D'Alimonte, Melanie Davidson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 29, 2018
Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials
Yasir Alayed, Patrick Cheung, Geordi Pang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2021
Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy Boost
Hima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 5, 2021
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of life
Hima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2016
Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate Cancer
Hima Bindu Musunuru, Melanie Davidson, Patrick Cheung, et al.
Page
of 3